Indian Company Master Data Made Simple
Ghl Pharma & Diagnostic Private Limited
With its incorporation dating back to 29 Jun 2022, Ghl Pharma & Diagnostic Private Limited has 3 years of experience. Ghl Pharma & Diagnostic Private Limited holds the CIN U85110DL2022PTC400942 and registration number 400942. It falls under the category of company limited by shares. The company has an authorized share capital of ₹15.00 crore. It has a paid-up capital totaling ₹10.01 crore.
Ghl Pharma & Diagnostic Private Limited primarily operates in human health activities. The company has been registered in the city of Delhi. The firm’s incorporation address reads E-18 Defence Colony, South Delhi, Delhi, Delhi, India, 110024. Currently, the company’s operational status is active. The company’s Permanent Account Number (PAN) is AAJCG8809P. The firm’s registered email for correspondence is compliance@medanta.org. At the helm are Anup Kumar Jha (CFO).
Company Overview
- CIN
- Date of Incorporation
- 29/06/2022
- Company Status
- Active
- RoC
- Delhi
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- No
- Class of Company
- Private Limited Company
- LEI Number
- Authorized Capital
- ₹15,00,00,000.00
- Paid up Capital
- ₹10,01,00,000.00
- Activity
- Human health activities
- compliance@medanta.org
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Bihar | 10AAJCG8809P1Z6 | Active |
| 10AAJCG8809P2Z5 | Active | |
| Delhi | 07AAJCG8809P2ZS | Active |
| 07AAJCG8809P1ZT | Active | |
| Haryana | 06AAJCG8809P1ZV | Active |
| 06AAJCG8809P2ZU | Active | |
| 06AAJCG8809P3ZT | Active | |
| Jharkhand | 20AAJCG8809P1Z5 | Active |
| 20AAJCG8809P2Z4 | Active | |
| Madhya Pradesh | 23AAJCG8809P2ZY | Active |
Financial Data
| Year | 2023 | 2024 |
|---|---|---|
| Assets | ₹1,501.90L | ₹2,603.30L |
| Liabilities | ₹730.90L | ₹3,127.50L |
| Equity | ₹771.00L | -₹524.20L |
| Income | ₹48.80L | ₹2,173.30L |
| Expenses | ₹278.80L | ₹3,473.20L |
| Profit before tax | -₹230.00L | -₹1,299.90L |
| Tax expense | - | - |
| Profit for period | - | - |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 29/06/2022 | Pankaj Prakash Sahni | 07132999 | Director | View other directorships |
| 29/06/2022 | Naresh Trehan | 00012148 | Director | View other directorships |
| 16/07/2022 | Rajdeep Panwar | 08943708 | Director | View other directorships |
| 01/09/2022 | Sanchit Ralhan | *****6254A | Company Secretary | |
| 01/01/2023 | Rajdeep Panwar | *****7914H | Manager | |
| 09/08/2023 | Anup Kumar Jha | *****2870R | CFO | |
| 20/03/2024 | Yogesh Kumar Gupta | 06627814 | Director | View other directorships |
Latest Documents
| Date | Title | Size |
|---|---|---|
| 15/11/2024 | Form MGT-7-15112024_signed.pdf | - |
| 27/09/2024 | Form AOC-4(XBRL)-27092024_signed.pdf | - |
| 04/01/2024 | Form MGT-7-04012024_signed.pdf | - |
| 14/11/2023 | Form MGT-7-14112023.pdf | - |
| 10/11/2023 | Form AOC-4(XBRL)-10112023_signed.pdf | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Blue Mountain Food Products Limited | U85110AP1979PLC064523 | No.11-8-34 Dasapalla Hills, Vishakhapatnam, Andhra Pradesh, India, 530003 |
| Dhulipalla Hospital Pvt Ltd | U85110AP1984PTC004427 | 12-14-16 Opp Sivalayam,,kothapet Guntur Ap Ap 522001 In |
| Dr Rangarao Nursing Home Private Limited | U85110AP1974PTC001729 | 13-2-66, Old Club Road,kothapet, Guntur, Andhra Pradesh, Andhra Pradesh, India, 522006 |
| Dr. Chhanda's Clinic (opc) Private Limited | U85110AN2023OPC005646 | C/o Mandal Chhanda, Brinda Clinic Garacharma Medical, South Andaman, Andaman Islands, Blair, Andaman And Nicobar Islands, India, 744103 |
| Vizag Nursing Home Pvt Ltd | U85110AP1983PTC004104 | No.9, Gangapur Tayat,visakhapatnam.,na,andhra Pradesh,000000-india |
Address
Frequently Asked Questions
The current board member of Ghl Pharma & Diagnostic Private Limited are:
- Pankaj Prakash Sahni
- Rajdeep Panwar
- Naresh Trehan
- Yogesh Kumar Gupta
Form MGT-7-15112024_signed.pdf